222 related articles for article (PubMed ID: 22101079)
1. Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer.
Chitasombat MN; Kofteridis DP; Jiang Y; Tarrand J; Lewis RE; Kontoyiannis DP
J Infect; 2012 Jan; 64(1):68-75. PubMed ID: 22101079
[TBL] [Abstract][Full Text] [Related]
2. Fungemia due to rare opportunistic yeasts: data from a population-based surveillance in Spain.
Fernández-Ruiz M; Guinea J; Puig-Asensio M; Zaragoza Ó; Almirante B; Cuenca-Estrella M; Aguado JM; ;
Med Mycol; 2017 Feb; 55(2):125-136. PubMed ID: 27495321
[TBL] [Abstract][Full Text] [Related]
3. Uncommon opportunistic yeast bloodstream infections from Qatar.
Taj-Aldeen SJ; AbdulWahab A; Kolecka A; Deshmukh A; Meis JF; Boekhout T
Med Mycol; 2014 Jul; 52(5):552-6. PubMed ID: 24934803
[TBL] [Abstract][Full Text] [Related]
4. Pseudozyma and other non-Candida opportunistic yeast bloodstream infections in a large stem cell transplant center.
Pande A; Non LR; Romee R; Santos CA
Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28099778
[TBL] [Abstract][Full Text] [Related]
5. Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia?
Kovacicova G; Krupova Y; Lovaszova M; Roidova A; Trupl J; Liskova A; Hanzen J; Milosovic P; Lamosova M; Macekova L; Szovenyiova Z; Purgelova A; Obertik T; Bille J; Krcmery V
J Infect Chemother; 2000 Dec; 6(4):216-21. PubMed ID: 11810569
[TBL] [Abstract][Full Text] [Related]
6. Species distribution and susceptibility profile of yeasts isolated from blood cultures: results of a multicenter active laboratory-based surveillance study in Argentina.
Córdoba S; Vivot W; Bosco-Borgeat ME; Taverna C; Szusz W; Murisengo O; Isla G; Davel G;
Rev Argent Microbiol; 2011; 43(3):176-85. PubMed ID: 22430989
[TBL] [Abstract][Full Text] [Related]
7. The epidemiology of non-Candida yeast isolated from blood: The Asia Surveillance Study.
Lin SY; Lu PL; Tan BH; Chakrabarti A; Wu UI; Yang JH; Patel AK; Li RY; Watcharananan SP; Liu Z; Chindamporn A; Tan AL; Sun PL; Hsu LY; Chen YC;
Mycoses; 2019 Feb; 62(2):112-120. PubMed ID: 30230062
[TBL] [Abstract][Full Text] [Related]
8. Five-year evaluation of bloodstream yeast infections in a tertiary hospital: the predominance of non-C. albicans Candida species.
Pereira GH; Müller PR; Szeszs MW; Levin AS; Melhem MS
Med Mycol; 2010 Sep; 48(6):839-42. PubMed ID: 20163281
[TBL] [Abstract][Full Text] [Related]
9. Comparison of fungemia caused by Candida and non-Candida rare yeasts: a retrospective study from a tertiary care hospital.
Oz Y; Yılmaz M; Bulduk T; Basayigit M; Gunduz E; Metintas S
Med Mycol; 2024 May; 62(5):. PubMed ID: 38627248
[TBL] [Abstract][Full Text] [Related]
10. Fungemia due to rare non-Candida yeasts between 2018 and 2021 in a Greek tertiary care university hospital.
Spiliopoulou A; Lekkou A; Vrioni G; Leonidou L; Cogliati M; Christofidou M; Marangos M; Kolonitsiou F; Paliogianni F
J Mycol Med; 2023 Aug; 33(3):101386. PubMed ID: 37031651
[TBL] [Abstract][Full Text] [Related]
11. Mixed fungaemia: an 18-year report from a tertiary-care university hospital and a systematic review.
Gülmez D; Alp S; Gursoy G; Ayaz CM; Dogan O; Arikan-Akdagli S; Akova M
Clin Microbiol Infect; 2020 Jul; 26(7):833-841. PubMed ID: 32246995
[TBL] [Abstract][Full Text] [Related]
12. [Multicenter study of fungemia due to yeasts in Argentina].
Rodero L; Davel G; Soria M; Vivot W; Córdoba S; Canteros CE; Saporiti A;
Rev Argent Microbiol; 2005; 37(4):189-95. PubMed ID: 16502638
[TBL] [Abstract][Full Text] [Related]
13. Infections caused by Candida lipolytica.
Lai CC; Lee MR; Hsiao CH; Tan CK; Lin SH; Liao CH; Huang YT; Hsueh PR
J Infect; 2012 Oct; 65(4):372-4. PubMed ID: 22750237
[No Abstract] [Full Text] [Related]
14. Fungaemia due to rare yeasts in a tertiary care university centre within 18 years.
Alp S; Gulmez D; Ayaz CM; Arikan-Akdagli S; Akova M
Mycoses; 2020 May; 63(5):488-493. PubMed ID: 32145101
[TBL] [Abstract][Full Text] [Related]
15. Evolution of fungemia in an Italian region.
Prigitano A; Cavanna C; Passera M; Gelmi M; Sala E; Ossi C; Grancini A; Calabrò M; Bramati S; Tejada M; Lallitto F; Farina C; Rognoni V; Fasano MA; Pini B; Romanò L; Cogliati M; Esposto MC; Tortorano AM
J Mycol Med; 2020 Apr; 30(1):100906. PubMed ID: 31708424
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and antifungal susceptibility of bloodstream fungal isolates in pediatric patients: a Spanish multicenter prospective survey.
Pemán J; Cantón E; Linares-Sicilia MJ; Roselló EM; Borrell N; Ruiz-Pérez-de-Pipaon MT; Guinea J; García J; Porras A; García-Tapia AM; Pérez-Del-Molino L; Suárez A; Alcoba J; García-García I
J Clin Microbiol; 2011 Dec; 49(12):4158-63. PubMed ID: 22012014
[TBL] [Abstract][Full Text] [Related]
17. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility and clinical outcomes of Candida parapsilosis bloodstream infections in a tertiary teaching hospital in Northern Taiwan.
Lin CC; Liu CP; Hsieh FC; Lee CM; Wang WS
J Microbiol Immunol Infect; 2015 Oct; 48(5):552-8. PubMed ID: 25315213
[TBL] [Abstract][Full Text] [Related]
19. Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital.
Posteraro B; Spanu T; Fiori B; De Maio F; De Carolis E; Giaquinto A; Prete V; De Angelis G; Torelli R; D'Inzeo T; Vella A; De Luca A; Tumbarello M; Ricciardi W; Sanguinetti M
Antimicrob Agents Chemother; 2015 Jul; 59(7):3944-55. PubMed ID: 25896705
[TBL] [Abstract][Full Text] [Related]
20. New and emerging yeast pathogens.
Hazen KC
Clin Microbiol Rev; 1995 Oct; 8(4):462-78. PubMed ID: 8665465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
